---
title: "D-Glucosamine Sulfate — Evidence, Benefits & Where to Buy | Magellan"
description: "D-Glucosamine Sulfate — D-Glucosamine sulfate is a salt of glucosamine, an amino monosaccharide the body synthesizes from glucose and uses as a building…"
url: "https://magellanlongevity.com/p/197.md"
canonical: "https://magellanlongevity.com/p/197.html"
html: "https://magellanlongevity.com/p/197.html"
type: "product"
section: "Nutraceuticals & Cellular Energizers"
evidence_grade: "Moderate evidence"
evidence_tier: "moderate"
citations: 21
product_id: 197
price_usd: 18.95
updated: 2026-09-02
author: "Gabriel Radu, DO"
author_credentials: "Physiatrist (PM&R). NY medical license 275110. NPI 1376861765."
publisher: "Magellan Longevity"
content_format: "markdown"
license: "Educational content — not medical advice"
---

# D-Glucosamine Sulfate

[Home](https://magellanlongevity.com/) › [Nutraceuticals & Cellular Energizers](https://magellanlongevity.com/c/1.md) › D-Glucosamine Sulfate

**HTML version:** https://magellanlongevity.com/p/197.html · **In the Magellan app:** https://magellanlongevity.com/#/product/197

## Key facts

| Field | Value |
| --- | --- |
| Product | D-Glucosamine Sulfate |
| Category | [Nutraceuticals & Cellular Energizers](https://magellanlongevity.com/c/1.md) |
| Evidence grade | Moderate evidence (B) |
| Peer-reviewed citations | 21 |
| Typical listed price | $18.95 (check the live price) |
| Where to buy | [Search Amazon](https://www.amazon.com/s?k=D-Glucosamine%20Sulfate&tag=magellanlong-20) |
| Catalog ID | 197 |

## What it is

D-Glucosamine sulfate is a salt of glucosamine, an amino monosaccharide the body synthesizes from glucose and uses as a building block for the glycosaminoglycans and proteoglycans that make up joint cartilage. It is among the most widely sold dietary supplements worldwide and is marketed chiefly for osteoarthritis of the knee, where it is classified as a symptomatic slow-acting drug for osteoarthritis (SYSADOA). In some countries prescription crystalline glucosamine sulfate is regulated as a drug, whereas in the United States glucosamine is sold as an over-the-counter supplement (typically 1500 mg/day).

## Its role in longevity

Evidence on glucosamine for aging-related joint health is genuinely mixed: in the landmark 3-year randomized trial of prescription crystalline glucosamine sulfate (n=212), placebo patients lost significant knee joint space (−0.31 mm) while glucosamine patients did not (−0.06 mm), with symptoms improving on glucosamine—yet the larger NIH GAIT trial found glucosamine alone no better than placebo overall, a 2018 JAMA meta-analysis found long-term pain control uncertain for all agents, and guidelines split between conditional support (ESCEO) and recommendation against (ACR/AAOS). Separately, large prospective cohorts such as UK Biobank link habitual glucosamine use to lower all-cause mortality (HR 0.85), cardiovascular disease, and type 2 diabetes risk, but these are observational, cannot establish causation, and have drawn published selection- and healthy-user-bias critiques. Safety is generally good, with cautions around warfarin interaction, shellfish allergy, and blood glucose. This evidence describes the glucosamine compound and its mechanisms as studied across many formulations and brands, not this specific commercial product.

## Evidence grade: Moderate evidence

- **What the grade means:** Curated grade based on the human and mechanistic evidence for this compound.
- **Dose used in studies:** Pivotal osteoarthritis trials used 1,500 mg/day of glucosamine sulfate, given once daily in the structure-modifying trials (Reginster 2001; Pavelka 2002); the GAIT trial used glucosamine hydrochloride 500 mg three times daily.
- **Dose from food:** There is essentially no dietary glucosamine: it is extracted from crab, shrimp and lobster shells (chitin), which people don't eat, so reaching the studied 1,500 mg/day from food is not realistic.
- **What this grade does not say:** Decades of trials are genuinely mixed: one 3-year RCT showed slowed knee joint-space narrowing, but the NIH GAIT trial and a 2018 JAMA meta-analysis found little to no pain benefit over placebo. The UK Biobank mortality association (HR ~0.85) is observational and has drawn published selection/healthy-user-bias critiques—longevity benefit is unproven. Generally safe and inexpensive; caution with warfarin, shellfish allergy, and blood glucose.

## Where it comes from without a bottle

Food, exercise and behaviour routes to the same pathway, each with its citation.

| Natural source | How it works | Citation |
| --- | --- | --- |
| Exercise (honest joint-support path) | There's almost no glucosamine in food, so the proven dietary/lifestyle route to healthier joints is exercise — a cornerstone of osteoarthritis care. | JAMA 2021 [PMID 33560326](https://pubmed.ncbi.nlm.nih.gov/33560326/) |
| Weight management | Losing excess weight unloads the knees and hips. With self-care and exercise it's a core, food-and-lifestyle way to protect aging joints. | Lancet 2019 [PMID 31034380](https://pubmed.ncbi.nlm.nih.gov/31034380/) |

### What those papers actually say

1. **Exercise (honest joint-support path)**
   JAMA 2021 · [PMID 33560326](https://pubmed.ncbi.nlm.nih.gov/33560326/) · [DOI 10.1001/jama.2020.22171](https://doi.org/10.1001/jama.2020.22171)

   > The cornerstones of OA management include exercises, weight loss if appropriate, and education-complemented by topical or oral nonsteroidal anti-inflammatory drugs

2. **Weight management**
   Lancet 2019 · [PMID 31034380](https://pubmed.ncbi.nlm.nih.gov/31034380/) · [DOI 10.1016/S0140-6736(19)30417-9](https://doi.org/10.1016/S0140-6736%2819%2930417-9)

   > Management should be tailored to the presenting individual and focus on core treatments, including self-management and education, exercise, and weight loss as relevant

## In the news

- **Glucosamine and Chondroitin for Osteoarthritis: What You Need To Know** — NCCIH (NIH) 2023 [Read it](https://www.nccih.nih.gov/health/glucosamine-and-chondroitin-for-osteoarthritis-what-you-need-to-know)
  > It's still uncertain whether glucosamine and chondroitin are helpful for knee osteoarthritis symptoms.
- **Do glucosamine and chondroitin supplements actually work for arthritis?** — Harvard Health Publishing 2022 [Read it](https://www.health.harvard.edu/blog/the-latest-on-glucosaminechondroitin-supplements-2016101710391)
  > Yet a number of past studies have come to mixed conclusions; some small studies, most looking at osteoarthritis of the knee, found that people felt modestly better taking glucosamine and/or chondroitin, but at least as many have found no benefit.
- **Glucosamine: Does it protect cartilage in osteoarthritis?** — Mayo Clinic 2024 [Read it](https://www.mayoclinic.org/diseases-conditions/osteoarthritis/expert-answers/glucosamine/faq-20058430)
  > Study results on this question have been mixed, with some suggesting possible benefit and some showing no benefit on cartilage protection.

## The research

Peer-reviewed studies on the active compound. Quotes are verbatim from the cited abstract. Research describes the active mechanism and is not a claim about this specific product.

### Cited studies

1. **Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study**
   Annals of the Rheumatic Diseases 2020 · [PMID 32253185](https://pubmed.ncbi.nlm.nih.gov/32253185/)

   > Regular glucosamine use was associated with significantly lower all-cause, cardiovascular, cancer, respiratory and digestive mortality (all-cause HR 0.73).

2. **Genetically predicted glucosamine and longevity: A Mendelian randomization study**
   Mendelian Randomization Analysis 2022 · [PMID 35623867](https://pubmed.ncbi.nlm.nih.gov/35623867/)

   > Higher genetically predicted glucosamine was associated with greater odds of extended parental lifespan, consistent with a causal effect on longevity.

3. **Glucosamine/Chondroitin and Mortality in a US NHANES Cohort**
   Frontiers in Pharmacology 2020 · [PMID 33219063](https://pubmed.ncbi.nlm.nih.gov/33219063/)

   > Glucosamine/chondroitin use was associated with reduced all-cause mortality in a nationally representative U.S. cohort.

4. **Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib**
   Annals of the Rheumatic Diseases 2016 · [PMID 25589511](https://pubmed.ncbi.nlm.nih.gov/25589511/) · [DOI 10.1136/annrheumdis-2014-206792](https://doi.org/10.1136/annrheumdis-2014-206792)

   > In the MOVES trial, glucosamine plus chondroitin had efficacy comparable to celecoxib in reducing pain, stiffness and functional limitation after 6 months in painful knee osteoarthritis, with a good safety profile.

5. **Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials**
   Journal of Orthopaedic Surgery and Research 2018 · [PMID 29980200](https://pubmed.ncbi.nlm.nih.gov/29980200/) · [DOI 10.1186/s13018-018-0871-5](https://doi.org/10.1186/s13018-018-0871-5)

   > A meta-analysis of randomized controlled trials found glucosamine improved stiffness outcomes and chondroitin relieved pain and physical function versus placebo in osteoarthritis.

6. **Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis.**
   Arch Orthop Trauma Surg 2023 · [PMID 35024906](https://pubmed.ncbi.nlm.nih.gov/35024906/) · [DOI 10.1007/s00402-021-04326-9](https://doi.org/10.1007/s00402-021-04326-9)

   > Our study confirmed that the combination of glucosamine and chondroitin is effective and superior to other treatments in knee osteoarthritis to a certain extent.

7. **Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.**
   N Engl J Med 2006 · [PMID 16495392](https://pubmed.ncbi.nlm.nih.gov/16495392/) · [DOI 10.1056/NEJMoa052771](https://doi.org/10.1056/NEJMoa052771)

   > Exploratory analyses suggest that the combination of glucosamine and chondroitin sulfate may be effective in the subgroup of patients with moderate-to-severe knee pain.

8. **Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis**
   JAMA 2018 · [PMID 30575881](https://pubmed.ncbi.nlm.nih.gov/30575881/) · [DOI 10.1001/jama.2018.19319](https://doi.org/10.1001/jama.2018.19319)

   > Associations with decreases in pain were found for glucosamine sulfate (SMD −0.29; 95% CrI −0.49 to −0.09); the association with pain improvement remained significant for glucosamine sulfate when trials at high risk of bias were excluded.

9. **Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank.**
   BMJ 2019 · [PMID 31088786](https://pubmed.ncbi.nlm.nih.gov/31088786/) · [DOI 10.1136/bmj.l1628](https://doi.org/10.1136/bmj.l1628)

   > Habitual use of glucosamine supplement to relieve osteoarthritis pain might also be related to lower risks of CVD events.

10. **Glucosamine Use, Inflammation, and Genetic Susceptibility, and Incidence of Type 2 Diabetes: A Prospective Study in UK Biobank.**
    Diabetes Care 2020 · [PMID 31988063](https://pubmed.ncbi.nlm.nih.gov/31988063/) · [DOI 10.2337/dc19-1836](https://doi.org/10.2337/dc19-1836)

    > Glucosamine use was associated with a significantly lower risk of T2D (hazard ratio 0.83, 95% CI 0.78-0.89) after adjustment for age, sex, BMI, race, center, Townsend deprivation index, lifestyle factors, history of disease, and other supplement use.

11. **Association between use of specialty dietary supplements and C-reactive protein concentrations.**
    Am J Epidemiol 2012 · [PMID 23139249](https://pubmed.ncbi.nlm.nih.gov/23139249/) · [DOI 10.1093/aje/kws186](https://doi.org/10.1093/aje/kws186)

    > Using survey-weighted multivariate linear regression, significant reductions in hs-CRP concentrations were associated with regular use of glucosamine (17%, 95% confidence interval (CI): 7, 26), chondroitin (22%, 95% CI: 8, 33), and fish oil (16%, 95% CI: 0.3, 29).

12. **Effectiveness and Safety of Glucosamine in Osteoarthritis: A Systematic Review.**
    Pharmacy (Basel) 2023 · [PMID 37489348](https://pubmed.ncbi.nlm.nih.gov/37489348/) · [DOI 10.3390/pharmacy11040117](https://doi.org/10.3390/pharmacy11040117)

    > To summarize, glucosamine is more effective than a placebo at reducing pain in knee osteoarthritis patients. In long-term treatment, oral glucosamine sulfate 1500 mg/day is believed to be well tolerated.

13. **Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis**
    Br J Sports Med 2018 · [PMID 29018060](https://pubmed.ncbi.nlm.nih.gov/29018060/) · [DOI 10.1136/bjsports-2016-097333](https://doi.org/10.1136/bjsports-2016-097333)

    > Of 20 supplements investigated in 69 studies, seven demonstrated large and clinically important effects for [osteoarthritis] pain reduction at short term.

14. **Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis.**
    Arch Intern Med 2003 · [PMID 12860572](https://pubmed.ncbi.nlm.nih.gov/12860572/) · [DOI 10.1001/archinte.163.13.1514](https://doi.org/10.1001/archinte.163.13.1514)

    > Our results demonstrated a highly significant efficacy of glucosamine on all outcomes, including joint space narrowing and WOMAC.

15. **Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials.**
    Ann Pharmacother 2005 · [PMID 15855241](https://pubmed.ncbi.nlm.nih.gov/15855241/) · [DOI 10.1345/aph.1E576](https://doi.org/10.1345/aph.1E576)

    > Glucosamine sulfate was more effective than placebo in delaying structural progression in knee OA. The risk of disease progression was reduced by 54% (pooled RR 0.46; 95% CI 0.28 to 0.73; p = 0.0011).

16. **Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta-analysis.**
    Inflammopharmacology 2024 · [PMID 38581640](https://pubmed.ncbi.nlm.nih.gov/38581640/) · [DOI 10.1007/s10787-024-01460-9](https://doi.org/10.1007/s10787-024-01460-9)

    > In the meta-analysis, CS showed a significant reduction in pain intensity, and improved physical function compared to the placebo; GS showed a significant reduction in tibiofemoral joint space narrowing.

17. **Comparative Efficacy of Glucosamine-Based Combination Therapies in Alleviating Knee Osteoarthritis Pain: A Systematic Review and Network Meta-Analysis.**
    J Clin Med 2024 · [PMID 39685902](https://pubmed.ncbi.nlm.nih.gov/39685902/) · [DOI 10.3390/jcm13237444](https://doi.org/10.3390/jcm13237444)

    > Glucosamine with omega-3 (G + omega-3, SMD -2.59 [95% CI -4.42 to -0.75], moderate quality) and glucosamine with ibuprofen (G + ibuprofen, SMD -2.27 [95% CI -3.73 to -0.82], moderate quality) significantly reduced overall pain compared to placebo.

18. **Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee.**
    West J Med 2000 · [PMID 10693368](https://pubmed.ncbi.nlm.nih.gov/10693368/) · [DOI 10.1136/ewjm.172.2.91](https://doi.org/10.1136/ewjm.172.2.91)

    > Glucosamine was no better than placebo in reducing pain from osteoarthritis of the knee in this group of patients.

19. **Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis.**
    Arthritis Rheum 2004 · [PMID 15478160](https://pubmed.ncbi.nlm.nih.gov/15478160/) · [DOI 10.1002/art.20697](https://doi.org/10.1002/art.20697)

    > In patients with knee OA with at least moderate subjective improvement with prior glucosamine use, this study provides no evidence of symptomatic benefit from continued use of glucosamine sulfate.

20. **Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.**
    Lancet (London, England) 2001 · [PMID 11214126](https://pubmed.ncbi.nlm.nih.gov/11214126/)

    > Over 3 years in 212 patients, placebo knees lost −0.31 mm of joint space while glucosamine sulfate knees lost only −0.06 mm (ns), with WOMAC symptoms improving on glucosamine versus slight worsening on placebo.

21. **Glucosamine and lower mortality and cancer incidence: Selection bias in the observational studies.**
    Pharmacoepidemiology and drug safety 2022 · [PMID 36029480](https://pubmed.ncbi.nlm.nih.gov/36029480/)

    > A methodological critique argues the lower mortality and cancer incidence attributed to glucosamine in observational cohorts are inflated by selection and healthy-user bias—longevity claims remain unproven.

## Where to buy

[Search Amazon for D-Glucosamine Sulfate](https://www.amazon.com/s?k=D-Glucosamine%20Sulfate&tag=magellanlong-20) — affiliate search link.

## Structured data

```json
{"@context":"https://schema.org","@graph":[{"@type":"ItemPage","@id":"https://magellanlongevity.com/p/197.html#page","url":"https://magellanlongevity.com/p/197.html","name":"D-Glucosamine Sulfate","description":"D-Glucosamine sulfate is a salt of glucosamine, an amino monosaccharide the body synthesizes from glucose and uses as a building block for the…","inLanguage":"en","isPartOf":{"@type":"WebSite","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"author":{"@type":"Person","name":"Gabriel Radu, DO","jobTitle":"Physiatrist (PM&R)","identifier":[{"@type":"PropertyValue","name":"NPI","value":"1376861765"},{"@type":"PropertyValue","name":"NY medical license","value":"275110"}]},"publisher":{"@type":"Organization","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"encoding":{"@type":"MediaObject","encodingFormat":"text/markdown","contentUrl":"https://magellanlongevity.com/p/197.md"},"dateModified":"2026-09-02"},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://magellanlongevity.com/"},{"@type":"ListItem","position":2,"name":"Nutraceuticals & Cellular Energizers","item":"https://magellanlongevity.com/c/1.html"},{"@type":"ListItem","position":3,"name":"D-Glucosamine Sulfate","item":"https://magellanlongevity.com/p/197.html"}]},{"@type":"Product","@id":"https://magellanlongevity.com/p/197.html#product","name":"D-Glucosamine Sulfate","category":"Nutraceuticals & Cellular Energizers","url":"https://magellanlongevity.com/p/197.html","description":"D-Glucosamine sulfate is a salt of glucosamine, an amino monosaccharide the body synthesizes from glucose and uses as a building block for the glycosaminoglycans and proteoglycans that make up joint cartilage. It is among the most widely sold dietary supplements worldwide and is marketed chiefly…","additionalProperty":[{"@type":"PropertyValue","name":"Evidence grade","value":"Moderate evidence"}],"offers":{"@type":"Offer","priceCurrency":"USD","price":"18.95","url":"https://www.amazon.com/s?k=D-Glucosamine%20Sulfate&tag=magellanlong-20","availability":"https://schema.org/InStock"}}]}
```

## Related on Magellan Longevity

- [Omega-3 EPA/DHA Fish Oil](https://magellanlongevity.com/p/128.md) — Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum triglycerides…
- [Creatine Monohydrate](https://magellanlongevity.com/p/123.md) — Across meta-analyses and randomized trials, creatine monohydrate combined with resistance training modestly…
- [Astaxanthin Softgels](https://magellanlongevity.com/p/107.md) — In humans, randomized trials and meta-analyses most consistently show that astaxanthin lowers the…
- [Zinc Picolinate](https://magellanlongevity.com/p/133.md) — Multiple meta-analyses of randomized trials indicate that oral zinc, started soon after symptom onset, can…
- [Vitamin K2 (MK-7)](https://magellanlongevity.com/p/138.md) — In humans, MK-7 supplementation consistently improves vitamin K-status biomarkers — lowering circulating…
- [All Nutraceuticals & Cellular Energizers](https://magellanlongevity.com/c/1.md)
- [Evidence-based longevity supplements](https://magellanlongevity.com/longevity-supplements.md)
- [Longevity research map](https://magellanlongevity.com/longevity-research-map.html)

## Scope and disclosures

Educational information, not medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement or device, especially if you are pregnant, nursing, or taking medication.

Editorial firewall: evidence grades are assigned from the published research and are independent of any affiliate commission. As an Amazon Associate, Magellan Longevity earns from qualifying purchases.

Reviewed for accuracy by a board-certified physician (DO).